Performances of the VitaPCR™ SARS‐CoV‐2 Assay during the second wave of the COVID‐19 epidemic in France
Finally, our observations confirm high usability and good appreciation of VitaPCR™ platform for its short duration of analysis (20 min), the little place occupied, and the possibility of point‐of‐care use, although only a single sample analysis is considered as a limiting factor. Furthermore, the analytical performances of the VitaPCR™ platform were high and close to […]
